CEO
Anthem Biosciences Limited
Equibles does not estimate personal net worth.
Ajay Bharadwaj is recorded as CEO at Anthem Biosciences Limited. Ajay Bharadwaj has spoken on 3 earnings calls across 1 company, most recently for Anthem Biosciences Limited on July 22, 2026. Anthem Biosciences Limited is classified in the Biotechnology industry within the Healthcare sector.
“I am pleased to announce our first quarter results for the financial year FY27. Our consolidated revenues from operations for the quarter were 418 crore rupees, out of which the CRDMO business contributed 81.5% of the revenues, delivering 341 crores.”
“At the outset, I'm very pleased to say we ended the financial year 25-26 on a very strong note. Our consolidated revenue from operations for the full year was 2,124 crore.”
“I would like to start by reporting that our consolidated revenue from operations for the nine months, ending on December 31st, 2025, for this financial year, that is, was 1,513 crores.”
Anthem Biosciences Limited
CEO
Transcript header (unverified)
Anthem Biosciences Limited
Biotechnology · Healthcare
CEO
Earnings Call for the Quarter Ended June 30, 2026
Anthem Biosciences Limited
Anthem Biosciences Limited Q4 & FY26 Earnings Conference Call
Anthem Biosciences Limited
“Anthem Biosciences Limited Q3 & 9M FY26 Earning Conference Call”
Anthem Biosciences Limited
